Lv1
60 积分 2021-04-29 加入
Pharmacokinetics of oral spironolactone in infants up to 2 years of age
2天前
已完结
Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure
1个月前
已完结
Pharmacokinetic properties and bioequivalence of spironolactone tablets in fasting and fed healthy Chinese male subjects
6个月前
已完结
Guidelines for the Management of Respiratory Infectious Diseases in Children in Japan 2022
8个月前
已完结
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adults
9个月前
已完结
Population Pharmacokinetic Analysis of Orally‐Administered Ruxolitinib (INCB018424 Phosphate) in Patients With Primary Myelofibrosis (PMF), Post‐Polycythemia Vera Myelofibrosis (PPV‐MF) or Post‐Essential Thrombocythemia Myelofibrosis (PET MF)
11个月前
已完结
The Effect of CYP3A4 Inhibition or Induction on the Pharmacokinetics and Pharmacodynamics of Orally Administered Ruxolitinib (INCB018424 Phosphate) in Healthy Volunteers
11个月前
已完结
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group
11个月前
已完结
Impact of molecular profiling on the management of patients with myelofibrosis
11个月前
已完结
The management of myelofibrosis: A British Society for Haematology Guideline
11个月前
已完结
皖公网安备34019202002308
